First City Capital Management, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
First City Capital Management, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$566,150
+0.9%
5,5580.0%0.36%
+7.3%
Q2 2023$560,870
-5.0%
5,558
-3.5%
0.33%
-4.1%
Q1 2023$590,610
+18.2%
5,758
+4.5%
0.34%
+14.6%
Q4 2022$499,644
+14.1%
5,508
-4.3%
0.30%
+4.2%
Q3 2022$438,000
-10.4%
5,758
-0.5%
0.29%
-4.0%
Q2 2022$489,000
-3.7%
5,7880.0%0.30%
+7.5%
Q1 2022$508,000
+4.5%
5,788
+2.7%
0.28%
+2.6%
Q4 2021$486,000
-12.7%
5,637
-17.2%
0.27%
-13.1%
Q3 2021$557,000
-12.0%
6,8120.0%0.31%
-9.8%
Q2 2021$633,000
+18.3%
6,812
+11.5%
0.35%
+12.3%
Q1 2021$535,000
-5.1%
6,107
-0.2%
0.31%
-14.1%
Q4 2020$564,000
-36.6%
6,117
-39.8%
0.36%
+9.4%
Q3 2020$889,000
+80.0%
10,163
+79.5%
0.33%
-12.9%
Q2 2020$494,000
+10.8%
5,662
+4.6%
0.38%
-13.3%
Q1 2020$446,000
-13.7%
5,411
-0.9%
0.44%
+22.8%
Q4 2019$517,000
+11.4%
5,461
+2.2%
0.36%
+5.0%
Q3 2019$464,000
-5.9%
5,342
-1.1%
0.34%
-5.6%
Q2 2019$493,000
-5.0%
5,4010.0%0.36%
-3.8%
Q1 2019$519,000
-5.5%
5,401
-15.6%
0.37%
-12.9%
Q4 2018$549,000
-2.1%
6,401
-1.6%
0.43%
+14.7%
Q3 2018$561,000
+14.3%
6,5060.0%0.37%
+6.3%
Q2 2018$491,000
-6.7%
6,5060.0%0.35%
-10.9%
Q1 2018$526,000
-3.7%
6,5060.0%0.39%
+5.9%
Q4 2017$546,000
-2.3%
6,5060.0%0.37%
-4.9%
Q3 2017$559,000
+2.9%
6,5060.0%0.39%
-0.8%
Q2 2017$543,000
+12.4%
6,5060.0%0.39%
+10.7%
Q1 2017$483,000
+1.5%
6,506
-0.4%
0.36%
-0.3%
Q4 2016$476,000
-99.9%
6,533
-0.4%
0.36%
-9.8%
Q3 2016$517,851,000
+95621.1%
6,5580.0%0.40%
-3.2%
Q2 2016$541,000
-99.9%
6,5580.0%0.41%
+25.8%
Q1 2016$475,062,000
-17.1%
6,558
-1.5%
0.32%
-15.6%
Q4 2015$572,854,000
-7.1%
6,658
-0.7%
0.38%
-15.0%
Q3 2015$616,599,000
-6.5%
6,7080.0%0.45%
-1.1%
Q2 2015$659,665,000
-9.5%
6,708
-9.2%
0.46%
-9.1%
Q1 2015$728,827,000
+2.6%
7,391
-3.6%
0.50%
+2.9%
Q4 2014$710,424,000
-4.7%
7,667
-3.2%
0.49%
-8.2%
Q3 2014$745,227,000
+1.9%
7,917
-2.0%
0.53%
+2.7%
Q2 2014$731,392,000
+4.5%
8,079
-1.8%
0.52%
+4.0%
Q1 2014$699,630,000
+4.5%
8,229
-1.2%
0.50%
-8.8%
Q4 2013$669,485,000
+4.3%
8,329
-0.5%
0.55%
+3.2%
Q3 2013$641,909,000
+10.6%
8,368
+2.0%
0.53%
+0.2%
Q2 2013$580,246,0008,2060.53%
Other shareholders
NOVARTIS A G shareholders Q3 2021
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders